Education
About Us
Working with TipRanks
Follow Us
Viking Therapeutics (VKTX)
NASDAQ:VKTX
VKTX Analyst Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VKTX Stock 12 Month Forecast
Average Price Target
$93.00
▲(180.80% Upside)
| Highest Price Target$125.00 | Average Price Target$93.00 | Lowest Price Target$70.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
BTIG
$125
Buy
277.42%
Upside
Reiterated
02/25/26
Canaccord Genuity
$107
Buy
223.07%
Upside
Reiterated
02/13/26
Truist Financial
―
Buy
―
Reiterated
02/12/26
Stifel Nicolaus
$95
Buy
186.84%
Upside
Reiterated
02/12/26
H.C. Wainwright
$102
Buy
207.97%
Upside
Reiterated
02/12/26
William Blair
―
Buy
―
Reiterated
02/12/26
Piper Sandler
$71
Buy
114.37%
Upside
Reiterated
02/12/26
Morgan Stanley
$102→$99
Buy
198.91%
Upside
Reiterated
02/12/26
Jefferies
$101
Buy
204.95%
Upside
Reiterated
02/12/26
J.P. Morgan
$75
Buy
126.45%
Upside
Reiterated
02/11/26
Maxim Group
$70
Buy
111.35%
Upside
Reiterated
02/11/26
Leerink Partners
$118
Buy
256.28%
Upside
Reiterated
10/23/25
Cantor Fitzgerald
$104→$105
Buy
217.03%
Upside
Reiterated
10/23/25
Oppenheimer
$100
Buy
201.93%
Upside
Reiterated
10/07/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BTIG
$125
Buy
277.42%
Upside
Reiterated
02/25/26
Canaccord Genuity
$107
Buy
223.07%
Upside
Reiterated
02/13/26
Truist Financial
―
Buy
―
Reiterated
02/12/26
Stifel Nicolaus
$95
Buy
186.84%
Upside
Reiterated
02/12/26
H.C. Wainwright
$102
Buy
207.97%
Upside
Reiterated
02/12/26
William Blair
―
Buy
―
Reiterated
02/12/26
Piper Sandler
$71
Buy
114.37%
Upside
Reiterated
02/12/26
Morgan Stanley
$102→$99
Buy
198.91%
Upside
Reiterated
02/12/26
Jefferies
$101
Buy
204.95%
Upside
Reiterated
02/12/26
J.P. Morgan
$75
Buy
126.45%
Upside
Reiterated
02/11/26
Maxim Group
$70
Buy
111.35%
Upside
Reiterated
02/11/26
Leerink Partners
$118
Buy
256.28%
Upside
Reiterated
10/23/25
Cantor Fitzgerald
$104→$105
Buy
217.03%
Upside
Reiterated
10/23/25
Oppenheimer
$100
Buy
201.93%
Upside
Reiterated
10/07/25
Best Analysts Covering Viking Therapeutics
3 Months
xxx
Success Rate
13/22 ratings generated profit
Average Return
+35.85%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +35.85% per trade.
1 Year
Success Rate
18/26 ratings generated profit
Average Return
+126.19%
a rating ―
Copying Naz Rahman's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +126.19% per trade.
2 Years
xxx
Success Rate
19/26 ratings generated profit
Average Return
+189.70%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 73.08% of your transactions generating a profit, with an average return of +189.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VKTX Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
29
20
18
10
15
Buy
8
5
5
4
4
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
38
25
23
14
19
Each month's total comprises the sum of three months' worth of ratings.
VKTX Financial Forecast
VKTX Stock Forecast FAQ
What is VKTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Viking Therapeutics’s 12-month average price target is 93.00.
What is VKTX’s upside potential, based on the analysts’ average price target?
Viking Therapeutics has 180.80% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VKTX a Buy, Sell or Hold?
Viking Therapeutics has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
What is Viking Therapeutics’s price target?
The average price target for Viking Therapeutics is 93.00. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $125.00 ,the lowest forecast is $70.00. The average price target represents 180.80% Increase from the current price of $33.12.
The highest analyst price target is $125.00 ,the lowest forecast is $70.00. The average price target represents 180.80% Increase from the current price of $33.12.
What do analysts say about Viking Therapeutics?
Viking Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of VKTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.